Patients with DM and encephalopathy had an increased percentage of CD4+ PD-1+ compared to remission patients with DM (14.9% [10.2–15] vs. 1.58% [0.71–1.84] p = 0.048) (Figure 5a). This evidence concerns the gene CD4 and dermatomyositis.